A clinical approach to the investigation and management of long COVID associated neuropathic pain

Eur Arch Psychiatry Clin Neurosci. 2024 Dec;274(8):1787-1795. doi: 10.1007/s00406-023-01721-8. Epub 2023 Dec 8.

Abstract

COVID-19 has been associated with a wide range of ongoing symptoms following recovery from the acute SARS-CoV-2 infection. Around one in three people with COVID-19 develop neurological symptoms with many reporting neuropathic pain and associated symptoms, including paraesthesia, numbness, and dysesthesia. Whilst the pathophysiology of long COVID-19-associated neuropathic pain remains unclear, it is likely to be multifactorial. Early identification, exclusion of common alternative causes, and a biopsychosocial approach to the management of the symptoms can help in relieving the burden of disease and improving the quality of life for patients.

Keywords: COVID-19; Long Covid; Neuropathy; Pain; Paraesthesia.

Publication types

  • Review

MeSH terms

  • COVID-19* / complications
  • Humans
  • Neuralgia* / etiology
  • Neuralgia* / therapy
  • Post-Acute COVID-19 Syndrome
  • SARS-CoV-2